PCOS: Clinical Trials

3 trials for PCOS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow PCOS: new trials by email Literature Review of PCOS trials Research Report on PCOS

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dampening the Reproductive Axis With Continuous Kisspeptin
kisspeptin 112-121 - Reproductive Disorder, PCOS
Phase 1CompletedStephanie B. Seminara, MD82023-10-062025-11-05
Kisspeptin Administration in the Adult
kisspeptin 112-121, GnRH - Hypogonadotropic Hypogonadism, Kallmann Syndrome
Phase 1CompletedMassachusetts General Hospital2562009-06-232024-07-31
Determining How Quickly Progesterone Slows LH Pulse Frequency
oral micronized progesterone suspension, Placebo - Normal, PCOS
Phase 1CompletedUniversity of Virginia852007-11-292025-03-28

Narrower conditions

Polycystic Ovary Syndrome (2)  ·  Hyperprolactinemia (1)  ·  Hypogonadism (1)  ·  Kallmann Syndrome (1)

Broader conditions

Adnexal Diseases (2)  ·  Cysts (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Gonadal Disorders (2)  ·  Neoplasms (2)  ·  Ovarian Cysts (2)  ·  Ovarian Diseases (2)  ·  Urogenital Diseases (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Congenital Abnormalities (1)

Interventions

Gonadotropin-Releasing Hormone (1)  ·  Progesterone (1)

Sponsors

Massachusetts General Hospital (1)  ·  Stephanie B. Seminara, MD (1)  ·  University of Virginia (1)

Countries

United States (3)

Top investigators

Stephanie B Seminara, MD (2)  ·  Christopher McCartney, MD (1)

Results publications

PMID 25226293, PMID 31132118, PMID 39965102, PMID 41273106

NIH funding

R01HD058671 (1)